Cardiovascular Monitoring and Diagnostic Devices Market, By Product Type (ECG Monitoring Device, Holter Monitoring Device, ECG Stress Testing, Event Monitoring Devices), By End User (Hospital, Ambulatory Surgical Centers, Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jul 2023

Code : CMI4021

Pages :150

Formats :

Excel and PDF

Industry : Medical Devices

Market News

Global Cardiovascular Monitoring and Diagnostic Devices Market: Key Developments

On May 6, 2023 Masimo, a U.S.-based medical technology company, announced that Radius VSM, a patient-worn, continuous multi-parameter vital signs monitor, has received U.S. FDA 510(k) clearance. Designed on a modular platform, Radius VSM allows clinicians to monitor a wide variety of physiological measurements, including Masimo SET pulse oximetry, non-invasive blood pressure, temperature, respiration rate, and electrocardiography (ECG). By combining the reliability and accuracy of larger bed-side monitors with the comfort and freedom of a wearable device, Radius allows ambulation and movement while ensuring patients remain continuously monitored.

On January 23, 2020, Biotronik, a Germany-based cardiovascular biomedical research and technology company, launches Next Generation Injectable Cardiac Monitor BIOMONITOR III. BIOMONITOR III’s unique BIOvector is designed to deliver high definition signals. As a result, the high signal amplitudes and visibility of the p-waves3 make it easier for the physician to confidently evaluate arrhythmias. BIOTRONIK’s next generation injectable cardiac monitor comes ready to inject, with the device pre-assembled in a one-step injection tool. The key feature with this new device is the long vector design which potentially captures not only the ventricular but also the atrial waves on the subcutaneous ECG which can provide a more accurate diagnosis.

Global Cardiovascular Monitoring and Diagnostic Devices Market: Key Trends

Strategies like collaborations by key market players

Increasing strategies like collaborations by key market players can drive growth of market. On November 8, 2022, OMRON Healthcare, Co., Ltd., a global healthcare company, announced a collaboration with Cardio Signal, a U.S.-based health technology company, aimed at bringing innovations in early cardiovascular disease detection to support clinicians at the forefront of Population Health management. Cardio Signal, a reliable and easy-to-use medical application that enables a smartphone to detect signs of atrial fibrillation, will be included in OMRON connect Premium Service in selected countries in Europe.